T
Todd H. Baron
Researcher at University of North Carolina at Chapel Hill
Publications - 818
Citations - 40963
Todd H. Baron is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Stent & Endoscopic retrograde cholangiopancreatography. The author has an hindex of 98, co-authored 795 publications receiving 36063 citations. Previous affiliations of Todd H. Baron include University of Rochester & Miles College.
Papers
More filters
Journal ArticleDOI
Endoscopic transpapillary gallbladder drainage for closure of calculous gallbladder perforation and cholecystoduodenal fistula.
TL;DR: The patient remained well for 4 weeks but then presented with recurrent right upper quadrant pain, fever, and leukocytosis with normal biochemical parameters of liver function, and he was referred to the authors' institution.
Journal ArticleDOI
Assessment of need for repeat ERCP during biliary stent removal after clinical resolution of postcholecystectomy bile leak
TL;DR: Patients with uncomplicated postcholecystectomy bile leak who have clinically resolved their leak do not require cholangiography at the time of stent removal and in these patients, EGD with stent removed at 4–6 weeks seems to be sufficient and significantly less expensive.
Journal ArticleDOI
A comprehensive review of endoscopic ultrasound core biopsy needles
Theodore W. James,Todd H. Baron +1 more
TL;DR: Endoscopic ultrasound-guided tissue acquisition by-fine needle biopsy (EUS-FNB) developed over the last two decades as an attempt to overcome the limitations of fine needle aspiration (FNA).
Journal ArticleDOI
EUS-directed transenteric ERCP in non-Roux-en-Y gastric bypass surgical anatomy patients (with video).
Yervant Ichkhanian,Juliana Yang,Theodore W. James,Todd H. Baron,Shayan Irani,John Nasr,Reem Z. Sharaiha,Ryan Law,Andreas Wannhoff,Mouen A. Khashab +9 more
TL;DR: EUS-directed transenteric ERCP using LAMSs is feasible and safe in patients with non-RYGB surgical anatomy and complex pancreaticobiliary pathologies, according to a multicenter retrospective study involving 7 centers.
Journal ArticleDOI
An updated review on ablative treatment of pancreatic cystic lesions
TL;DR: The development and use of EUS cyst ablation is a minimally invasive alternative in treating pancreatic cystic lesions (PCLs) and this review focuses on the modalities of ethanol ablation, paclitaxel ablated, and radiofrequency ablation of PCLs.